Weekly Newsletter   Challenge account   Weekly Newsletter   


Markets held 2700 support today

S&P PanicAs posted earlier I identified a support at 2700 level (or around) and today, the market held that level although the trend was gloomy. I expected more turmoil in regards to FED (which is still coming on us) and Trump’s tariffs (this still can come back and spook the investors who already crapped their pants enough this last two weeks).

For our funds, trading was slow today. I was busy with other things and also wasn’t in mood of trading. So I decided to skip it. I did only a handful trades today, and I bought a new dividend aristocrat to our portfolio


 

My trading was very slow today as I had no time to watch the market. We only opened one single new trade using SPX with tomorrow’s expiration and added a few new call spreads to the existing open put positions (see below). As Mr. Market is usually going to punish me for opening both sides of the options chain, I hope that by adding the call spreads the stocks will finally move upwards (which will be my call spreads punishment) but the things will finally move. At least I am already seeing a strong move in AMZN and one call side is dangerously close. I might be forced to convert that into puts and a never ending tail-spin can continue.

 

 · Trading activity today

 

A summary of opening and closing trades.
(balance + $172.00)

 
0309trading
 

 

 · Dividend stocks to buy

 

Out of our watch list of 36 dividend stocks the following ones are a good buy at today’s prices (03/19/2018):
 

ABBV
AGNC
AWK
CVX
HD
KMB
MCD
OXY
PG
PPL
XOM
 

Last week, we made nice cash and it is our plan to use 50% of the options trading proceeds to buy dividend growth stocks from our watch list.
 

Today, we have purchased the following stocks using the strategy mentioned above:
 

Abbvie (ABBV)

 


Disclaimer: The list above is based on calculated fair value and 52wk high offset valuation. The values are subjective to our calculations and opinion and may differ from your own. If you decide to trade or buy these stocks, do so on your own risk and do your own homework. The list is not our recommendation to you.

 





Leave a Reply

Your email address will not be published. Required fields are marked *